These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6317769)

  • 41. [A case of Wegener's granulomatosis complicated with cytomegalovirus pneumonia during the treatment with immunosuppressants].
    Kondo Y; Matsuse H; Machida I; Kawano T; Tomari SY; Izaki K; Shimoda T; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 2002 Jul; 40(7):569-73. PubMed ID: 12382420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytomegalovirus pneumonia in bone marrow transplant recipients: miliary and diffuse patterns.
    Beschorner WE; Hutchins GM; Burns WH; Saral R; Tutschka PJ; Santos GW
    Am Rev Respir Dis; 1980 Jul; 122(1):107-14. PubMed ID: 6250434
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cytomegalovirus infections after renal transplant].
    Solá R; Caralps A; Andreu J; Ricart MJ; Brulles A; Vilardell J; Oppenheimer F; Gil Vernet JM; Beltrán M
    Rev Clin Esp; 1980 Dec; 159(5):349-54. PubMed ID: 6261312
    [No Abstract]   [Full Text] [Related]  

  • 44. Factors contributing to the risk of cytomegalovirus infection in patients receiving renal transplants.
    Ho M; Dowling JN; Armstrong JA; Suwansirikul S; Wu B; Youngblood LA; Saslow A
    Yale J Biol Med; 1976 Mar; 49(1):17-26. PubMed ID: 183377
    [No Abstract]   [Full Text] [Related]  

  • 45. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
    Lochmanova A; Lochman I; Tomaskova H; Marsalkova P; Raszka J; Mrazek J; Dedochova J; Martinek A; Brozmanova H; Grundmann M
    Transplant Proc; 2010 Nov; 42(9):3574-7. PubMed ID: 21094818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of renal transplants obtained from anti-HCV positive donors.
    Gómez E; Aguado S; Gago E; Martinez A; Cimadevilla R; Melón S; de Oña M; Alvarez-Grande J
    Transplant Proc; 1991 Oct; 23(5):2654-5. PubMed ID: 1656567
    [No Abstract]   [Full Text] [Related]  

  • 47. Incidence of cytomegalovirus infection in kidney recipients.
    Bilgin N; Karakayali H; Moray G; Akkoç H; Turan M
    Transplant Proc; 1996 Aug; 28(4):2314-5. PubMed ID: 8769233
    [No Abstract]   [Full Text] [Related]  

  • 48. Cytomegalovirus infection after renal transplantation. Pulmonary dysfunction measured by decreased diffusing capacity for carbon monoxide in patients with symptomatic and asymptomatic infection.
    van Son WJ; Peset R; Duipmans JC; van der Mark TW; The TH; Tegzess AM
    Transplantation; 1987 Jul; 44(1):149-50. PubMed ID: 3037737
    [No Abstract]   [Full Text] [Related]  

  • 49. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aetiology of pulmonary diseases in immunocompromised patients.
    Heurlin N; Brattström C; Lönnqvist B; Westman L; Lidman C; Andersson J
    Eur Respir J; 1991 Jan; 4(1):10-8. PubMed ID: 1851103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
    Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
    Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
    Ketteler M; Preuschof L; Mertz A; Stöffler-Meilicke M; Schäfer H; Distler A; Offermann G
    Clin Nephrol; 2000 Nov; 54(5):418-24. PubMed ID: 11105806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytomegalovirus infection in high-risk kidney transplant recipients receiving thymoglobulin induction-a single-center experience.
    Puttarajappa C; Bhattarai M; Mour G; Shen C; Sood P; Mehta R; Shah N; Tevar AD; Humar A; Wu C; Hariharan S
    Clin Transplant; 2016 Sep; 30(9):1159-64. PubMed ID: 27423138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytomegalovirus disease in renal transplant recipients: a single-center experience.
    Cavdar C; Celtik A; Saglam F; Sifil A; Atila K; Celik A; Tosun P; Olmuscelik O; Bora S; Gulay H; Camsari T
    Ren Fail; 2008; 30(5):503-6. PubMed ID: 18569930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group.
    Snydman DR; Werner BG; Dougherty NN; Griffith J; Rohrer RH; Freeman R; Jenkins R; Lewis WD; O'Rourke E
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):23-7. PubMed ID: 7940972
    [No Abstract]   [Full Text] [Related]  

  • 56. A cytomegalovirus vaccine tames the troll of transplantation.
    Schleiss MR
    Lancet; 2011 Apr; 377(9773):1216-8. PubMed ID: 21481691
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular rejection of renal allografts is linked to CMV IgG, positive organ donor.
    Tenschert W; Dittmer R; Harfmann P; Cremaschi L; Meyer-Moldenhauer WH; Arndt R; Klosterhalfen H
    Transplant Proc; 1991 Oct; 23(5):2641-2. PubMed ID: 1656565
    [No Abstract]   [Full Text] [Related]  

  • 59. Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials.
    Snydman DR; Werner BG; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS; Strom TB; Carpenter CB
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1357-60. PubMed ID: 1846464
    [No Abstract]   [Full Text] [Related]  

  • 60. Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation.
    Leone F; Gigliotti P; Mauro MV; Lofaro D; Greco F; Tenuta R; Perugini D; Papalia T; Mollica A; Perri A; Vizza D; La Russa A; Toteda G; Lupinacci S; Giraldi C; Bonofiglio R
    Transpl Infect Dis; 2016 Apr; 18(2):191-201. PubMed ID: 26878346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.